BIOTRONIK and Charité Launch Partnership to Advance Digital Cardiology in Berlin

May 19, 2026
BIOTRONIK, Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation have announced a new partnership to drive research and innovation in digital and translational cardiology, focusing on AI tools and connected health technologies.

BIOTRONIK, Charité Berlin, and the German Heart Center Foundation announced in a press release a research and innovation partnership focused on advancing digital and translational cardiology. The collaboration aims to strengthen Berlin's position as a hub for digital cardiovascular medicine.

The initiative combines clinical expertise from the Deutsches Herzzentrum der Charité with BIOTRONIK's technology in active cardiac devices, artificial intelligence, and connected health. The cooperation will cover the full research spectrum from early ideation to joint development and contract research.

Initial projects will focus on developing AI based tools and advanced simulation environments to enhance device therapies. The partnership also supports the creation of an endowed professorship for Digital and Translational Cardiology at Charité, jointly funded by BIOTRONIK and the German Heart Center Foundation. This professorship will attract international researchers and accelerate innovation in cardiovascular care.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

05/19
BIG Fiber Secures $250 Million Financing to Expand Dark Fiber Network
05/19
Rockwell Automation Report Shows 90 Percent of Manufacturers See Digital Transformation as Essential
05/19
REI Systems Introduces GovOrch AI for Cross-System Government Data Access
05/19
ZTE Highlights AI and Network Integration at GSMA M360 LATAM 2026
05/19
Labbit Introduces Validation Assistant for Automated System Revalidation

More from: Life Sciences

05/19
Mayo Clinic and Bayesian Health Create AI Tool for Early Palliative Care Identification
05/19
ACROBiosystems Showcases AI Protein Engineering at Zurich Innovation Day
05/19
Labbit Introduces Validation Assistant for Automated System Revalidation
05/19
Shaman Introduces Shaman Atlas for Pharma Content Extraction
05/19
Enhanced Partners with Rezolve Ai to Build AI Technology for Live Enhanced Platform

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like